|
Volumn 43, Issue 4, 2009, Pages 386-
|
The A2143G point mutation of clarithromycin resistance affects helicobacter pylori eradication
a a b c d b a d |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLARITHROMYCIN;
ANTIINFECTIVE AGENT;
BACTERIAL DNA;
ANTIBIOTIC RESISTANCE;
DNA DETERMINATION;
DRUG EFFICACY;
GENOTYPE;
HELICOBACTER INFECTION;
HUMAN;
LETTER;
MEDICAL PRACTICE;
POINT MUTATION;
PREDICTION;
PREVALENCE;
PRIORITY JOURNAL;
REAL TIME POLYMERASE CHAIN REACTION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
DRUG EFFECT;
GENETICS;
HELICOBACTER PYLORI;
METHODOLOGY;
MICROBIOLOGY;
POLYMERASE CHAIN REACTION;
ANTI-BACTERIAL AGENTS;
CLARITHROMYCIN;
DNA, BACTERIAL;
DRUG RESISTANCE, BACTERIAL;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 65549159600
PISSN: 01920790
EISSN: None
Source Type: Journal
DOI: 10.1097/MCG.0b013e318178d1e7 Document Type: Letter |
Times cited : (11)
|
References (5)
|